These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


99 related items for PubMed ID: 7855939

  • 1. Prostaglandin E1 versus linsidomine chlorhydrate in erectile dysfunction.
    Wegner HE, Knispel HH, Klän R, Meier T, Miller K.
    Urol Int; 1994; 53(4):214-6. PubMed ID: 7855939
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of linsidomine chlorhydrate, a direct nitric oxide donor, in the treatment of human erectile dysfunction: results of a double-blind cross over trial.
    Wegner HE, Knispel HH, Klän R, Miller K.
    Int J Impot Res; 1995 Dec; 7(4):233-7. PubMed ID: 8770666
    [Abstract] [Full Text] [Related]

  • 3. Effect of nitric oxide-donor, linsidomine chlorhydrate, in treatment of human erectile dysfunction caused by venous leakage.
    Wegner HE, Knispel HH.
    Urology; 1993 Oct; 42(4):409-11. PubMed ID: 8212440
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Pharmacological therapy in erectile dysfunction--current standards and new viewpoint].
    Schultheiss D, Stief CG, Truss MC, Jonas U.
    Wien Med Wochenschr; 1997 Oct; 147(4-5):102-4. PubMed ID: 9190765
    [Abstract] [Full Text] [Related]

  • 6. Preliminary results with the nitric oxide donor linsidomine chlorhydrate in the treatment of human erectile dysfunction.
    Stief CG, Holmquist F, Djamilian M, Krah H, Andersson KE, Jonas U.
    J Urol; 1992 Nov; 148(5):1437-40. PubMed ID: 1433545
    [Abstract] [Full Text] [Related]

  • 7. Role of the nitric oxide donor linsidomine chlorhydrate (SIN-1) in the diagnosis and treatment of erectile dysfunction.
    Truss MC, Becker AJ, Djamilian MH, Stief CG, Jonas U.
    Urology; 1994 Oct; 44(4):553-6. PubMed ID: 7941195
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Topical prostaglandin E1 SEPA gel for the treatment of erectile dysfunction.
    McVary KT, Polepalle S, Riggi S, Pelham RW.
    J Urol; 1999 Sep; 162(3 Pt 1):726-30; discussion 730-1. PubMed ID: 10458353
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intracavernous injection of prostaglandin E1 in spinal cord injured patients with erectile dysfunction. A preliminary report.
    Tang SF, Chu NK, Wong MK.
    Paraplegia; 1995 Dec; 33(12):731-3. PubMed ID: 8927414
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Efficacy and safety of PGE1 cream in the treatment of erectile dysfunction].
    Jiang H, Xu QQ, Hong K, Wang XF, Zhu JC.
    Zhonghua Nan Ke Xue; 2003 Apr; 9(2):97-9. PubMed ID: 12749125
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.